antibiotic resistance
Accelerate Dx, Bruker Collaborate on Workflow for Postive Blood Culture ID
The companies will validate the use of Accelerate's Arc system for automated positive blood culture sample preparation with Bruker's MALDI Biotyper.
Oxford Nanopore Technologies, Day Zero Diagnostics Partner to Develop Sepsis Dx
Day Zero Diagnostics has also signed an agreement to use Oxford Nanopore's platforms as part of its epiXact lab services for commercial customers.
Gradientech Inks UK, Ireland Distribution Deal for Antimicrobial Susceptibility Testing System
The agreement adds to a growing list of distribution and commercialization agreements for the QuickMIC system in European countries.
Day Zero Diagnostics Aiming to Bring Whole-Genome Sequencing Pathogen ID/AST to Clinical Labs
Premium
The firm intends to use new funding to move its platform into the clinical trial stage in the pursuit of an FDA-regulated IVD product.
The Glaswegian company plans to commence a clinical feasibility study of its point-of-care diagnostic platform next year.